Members |
targetComponentId |
Peanut - dietary |
Peanut (substance) |
Pear - dietary |
Pear (substance) |
Pectobacterium chrysanthemi |
Dickeya chrysanthemi (organism) |
Pectoralis major myocutaneous flap plus rib |
Pectoralis major osteomyocutaneous flap of rib |
Pediatric food panel mix radioallergosorbent test |
Food mix specific IgE antibody measurement |
Pedicle flap reconstruction - action |
Flap reconstruction - action |
Pedicle transverse rectus abdominus flap |
Pedicle transverse rectus abdominis myocutaneous flap (substance) |
Pediculus humanus humanus |
Pediculus humanus (organism) |
Pediococcus urinae-equi |
Aerococcus urinaeequi (organism) |
Peeling - action |
Stripping - action |
Pegaptanib 0.3mg intravitreal injection solution 1mL prefilled syringe |
Pegaptanib (as pegaptanib sodium) 3.33 mg/mL solution for injection |
Peginterferon alfa-2a 135micrograms/0.5mL solution for injection prefilled syringe |
Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Peginterferon alfa-2a 180micrograms/0.5mL solution for injection prefilled syringe |
Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection |
Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial |
Peginterferon alfa-2b 100micrograms powder for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
Peginterferon alfa-2b 100micrograms powder+solvent for solution for injection in prefilled pen |
Peginterferon alfa-2b only product in parenteral dose form |
Peginterferon alfa-2b 120micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 120micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen |
Peginterferon alfa-2b 150micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen |
Peginterferon alfa-2b 50micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen |
Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
Peginterferon alfa-2b 80micrograms powder+solvent for solution for injection in prefilled pen |
Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen |
Pegvisomant 30mg powder for injection solution vial |
Pegvisomant 20 mg powder for solution for injection vial |
Pelvic contrast radiography |
Plain X-ray of pelvis with contrast (procedure) |
Pelvic contrast radiography |
Plain X-ray of pelvis with contrast (procedure) |
Pelvic exenteration, female |
Pelvic exenteration |
Pelvic floor repair |
Repair of vaginal enterocele |
Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
Pelvic lymphangiogram |
Fluoroscopic lymphangiography of pelvis with contrast (procedure) |
Pelvic lymphangiography, bilateral |
Fluoroscopic lymphangiography of bilateral pelvis with contrast (procedure) |
Pelvic soft tissue X-ray |
Plain X-ray of soft tissue of pelvis (procedure) |
Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium with antenatal problem |
Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium |
Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium with postnatal complication |
Pelvic soft tissue abnormality in pregnancy, childbirth and the puerperium |
Pelvic somatic dysfunction |
Impaired or altered function of related components of the body framework system: skeletal, arthrodial and myofascial structures, and their related vascular, lymphatic and neural elements. It is characterized by positional asymmetry, restricted range of motion, tissue texture abnormalities, and/or tenderness. The positional and motion aspects of somatic dysfunction are generally described by: (1) The position of a body part as determined by palpation and referenced to its defined adjacent structure, (2) The directions in which motion is freer, and (3) The directions in which motion is restricted. Somatic dysfunction is treatable using osteopathic manipulative treatment. |
Pelvis X-ray |
Plain X-ray of pelvis (procedure) |
Penetrating injury caused by glass |
Penetrating injury caused by glass fragment |
Penetrating injury due to glass |
Penetrating injury caused by glass fragment |
Penetrating wound of orbit without mention of foreign body |
Penetrating wound of orbit |
Penetrating wound of orbit without mention of foreign body |
Penetrating wound of orbit |
Penicillin G benzathine 300,000unit/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin antibacterial overdose |
Penicillin overdose |
Penicillin g benzathine 150000iu/penicillin g procaine 150000iu powder for injection solution vial |
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection suspension 10mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 300,000unt/mL injection suspension 1mL vial |
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g benzathine 600,000unt/mL injection suspension 1mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 20mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 2mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 600,000unt/mL injection suspension 4mL vial |
Benzathine benzylpenicillin 600000 unit/mL suspension for injection |
Penicillin g benzathine 900000iu/penicillin g procaine 300000iu powder for injection solution vial |
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection |
Penicillin g procaine 600,000unt/mL injection suspension 1mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin g procaine 600,000unt/mL injection suspension 4mL vial |
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) |
Penicillin poisoning NOS |
Poisoning caused by penicillin (disorder) |
Penicillin v potassium 500mg |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
Penicillin v potassium 500mg tablet |
Product containing precisely phenoxymethylpenicillin (as phenoxymethylpenicillin potassium) 500 milligram/1 each conventional release oral tablet (clinical drug) |
Penicillium mycetogenum |
Penicillium mycetomagenum |
Penicillium patulum |
Penicillium griseofulvum |
Penicillium rubrum |
Talaromyces purpureogenus (organism) |
Penicillium rubrum toxicosis |
Penicillium purpurogenum toxicosis (disorder) |
Penicilloyl G extract |
Product containing benzylpenicillin (medicinal product) |
Penicilloyl V extract |
Phenoxymethylpenicillin-containing product |
Penile disorders NOS |
Disorder of penis |
Penile disorders NOS |
Disorder of penis |
Pentamidine isethionate 300mg injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
Pentamidine isethionate 300mg/5mL nebulizer solution |
Product containing precisely pentamidine isethionate 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Pentamidine isethionate 300mg/vial injection |
Pentamidine isetionate 300 mg powder for solution for injection vial |
Pentasa 1g/100mL retention enema |
Mesalazine only product in rectal dose form |
Pentastarch 10% infusion solution bottle |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10% injection solution bag |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10g/100mL conventional release solution for infusion 500mL bag |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10g/100mL injection |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 10g/100mL intravenous solution 500mL bag |
Pentastarch 100 mg/mL solution for injection |
Pentastarch 6% in sodium chloride 7.2% conventional release solution for injection |
Product containing only pentastarch (medicinal product) |
Pentastarch 6% in sodium chloride 7.2% intravenous infusion |
Product containing only pentastarch (medicinal product) |
Pentastarch 6% infusion solution bottle |
Product containing precisely pentastarch 60 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Pentastarch allergy |
Non-allergic hypersensitivity to pentastarch |
Pentobarbital sodium 18.2mg/5ml elixir |
Product containing precisely pentobarbital sodium 3.64 milligram/1 milliliter conventional release oral solution (clinical drug) |
Pentobarbital sodium 20mg/5ml elixir |
Pentobarbital sodium 4 mg/mL oral solution |
Pentose shunt pathway |
Pentose shunt pathway |
Pentostatin 10mg injection |
Pentostatin 10 mg powder for solution for injection vial |
Pentosyltransferase |
Pentosyltransferase |
People's democratic republic of Yemen |
Yemen (geographic location) |
Pepsin specific extract |
Product containing pepsin A (medicinal product) |
Peptic reflux disease |
Gastro-oesophageal reflux disease with oesophagitis |
Peptic ulcer NOS |
Peptic ulcer |
Peptic ulcer NOS |
Peptic ulcer |
Peptide hydrolase |
Peptide hydrolase |
Peptostreptococcus hydrogenalis |
Anaerococcus hydrogenalis (organism) |
Peptostreptococcus lactolyticus |
Anaerococcus lactolyticus (organism) |
Peptostreptococcus magnus |
Finegoldia magna (organism) |
Peptostreptococcus octavius |
Anaerococcus octavius (organism) |
Peptostreptococcus parvulus |
Lancefieldella parvula |
Peptostreptococcus prevotii |
Anaerococcus prevotii (organism) |
Peptostreptococcus productus |
Blautia producta |
Peptostreptococcus vaginalis |
Anaerococcus vaginalis (organism) |
Perceptual disturbance due to alcohol withdrawal |
Perceptual disturbance due to alcohol withdrawal (disorder) |
Percussion vibrator technique |
A treatment strategy where the initial movements are indirect; as the technique is completed the movements change to direct forces; A manipulative sequence involving two or more different osteopathic manipulative treatment method (e.g., Spencer technique combined with muscle energy technique). |
Percutaneous cholangiogram |
Percutaneous fluoroscopic cholangiography with contrast (procedure) |